These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 444408)

  • 1. Ratio of 11-desoxy 17-oxosteroids to creatinine in a population screened for breast cancer.
    Poortman J; van der Smissen J; Collette HJ; de Waard F
    Br J Cancer; 1979 Jun; 39(6):688-95. PubMed ID: 444408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined effect of childbearing, menstrual events, and body size on age-specific breast cancer risk.
    Kampert JB; Whittemore AS; Paffenbarger RS
    Am J Epidemiol; 1988 Nov; 128(5):962-79. PubMed ID: 3189296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for breast cancer in women undergoing mammography.
    Reuter KL; Baker SP; Krolikowski FJ
    AJR Am J Roentgenol; 1992 Feb; 158(2):273-8. PubMed ID: 1729780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary epidermal growth factor excretion and breast cancer risk.
    Wang DY; Mockridge CI; Fantl VE; de Stavola B; Allen DS; Thomas BS; Moore JW; Bulbrook RD; Gravelle IH; Kwa HG
    Eur J Cancer Clin Oncol; 1988 Jun; 24(6):1049-53. PubMed ID: 3261690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on circadian periodicity of urinary corticoids in carcinoma of the breast.
    Singh R; Singh RK; Mahdi AA; Misra S; Rai SP; Singh D; Cornélissen G; Halberg F
    In Vivo; 1998; 12(1):69-73. PubMed ID: 9575428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between steroid excretion patterns and breast cancer incidence in Israeli women of various origins.
    Gross J; Modan B; Bertini B; Spira O; de Waard F; Thijssen JH; Vestergaard P
    J Natl Cancer Inst; 1977 Jul; 59(1):7-11. PubMed ID: 875063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reproductive and hormonal factors and breast cancer in a Northern Italian population.
    Talamini R; La Vecchia C; Franceschi S; Colombo F; Decarli A; Grattoni E; Grigoletto E; Tognoni G
    Int J Epidemiol; 1985 Mar; 14(1):70-4. PubMed ID: 3988443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary excretion of isoflavonoids and the risk of breast cancer.
    Zheng W; Dai Q; Custer LJ; Shu XO; Wen WQ; Jin F; Franke AA
    Cancer Epidemiol Biomarkers Prev; 1999 Jan; 8(1):35-40. PubMed ID: 9950237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for breast cancer.
    Helmrich SP; Shapiro S; Rosenberg L; Kaufman DW; Slone D; Bain C; Miettinen OS; Stolley PD; Rosenshein NB; Knapp RC; Leavitt T; Schottenfeld D; Engle RL; Levy M
    Am J Epidemiol; 1983 Jan; 117(1):35-45. PubMed ID: 6823951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma prolactin levels and breast cancer: relation to parity, weight and height, and age at first birth.
    Kwa HG; Cleton F; Bulbrook RD; Wang DY; Hayward JL
    Int J Cancer; 1981 Jul; 28(1):31-4. PubMed ID: 7309279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics that predict risk of breast cancer before and after the menopause.
    Paffenbarger RS; Kampert JB; Chang HG
    Am J Epidemiol; 1980 Aug; 112(2):258-68. PubMed ID: 7416152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiologic characteristics of breast cancer in three menopausal stages: preliminary findings.
    Paffenbarger RS; Greenberg LM; Chang HG; Kampert JB
    Natl Cancer Inst Monogr; 1979 Nov; (53):195-202. PubMed ID: 537627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basic results of a study of bilateral adrenalectomy for advanced breast cancer. Urinary steroids and related data in 148 patients.
    Sarfaty G; Pitt P; Tallis M
    Med J Aust; 1973 Nov; 2(19):877-81. PubMed ID: 4128906
    [No Abstract]   [Full Text] [Related]  

  • 14. Benign and malignant breast disease in South Wales: a study of urinary steroids.
    Cameron EH; Griffiths K; Gleave E; Stewart HJ; Forrest AP; Campbell H
    Br Med J; 1970 Dec; 4(5738):768-71. PubMed ID: 4250592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interrelations between 17 ketosteroids, 17 ketogenic steroids, body weight, and height in normal and obese women.
    Recker RR; Saville PD; Heaney RP
    Nebr Med J; 1974 Jul; 59(7):231-5. PubMed ID: 4852520
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of family history, body-fat distribution, and reproductive factors on the risk of postmenopausal breast cancer.
    Sellers TA; Kushi LH; Potter JD; Kaye SA; Nelson CL; McGovern PG; Folsom AR
    N Engl J Med; 1992 May; 326(20):1323-9. PubMed ID: 1565145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary oestrogen excretion after the menopause in relation to age and body mass.
    Mole PA; Rae MH; Paterson CR
    Ann Nutr Metab; 1989; 33(5):246-51. PubMed ID: 2624434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An epidemiologic study of breast cancer.
    Choi NW; Howe GR; Miller AB; Matthews V; Morgan RW; Munan L; Burch JD; Feather J; Jain M; Kelly A
    Am J Epidemiol; 1978 Jun; 107(6):510-21. PubMed ID: 665665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for adenocarcinoma of the cervix: a case-control study.
    Parazzini F; La Vecchia C; Negri E; Fasoli M; Cecchetti G
    Br J Cancer; 1988 Feb; 57(2):201-4. PubMed ID: 3358912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for pathologically confirmed benign breast disease.
    Parazzini F; La Vecchia C; Franceschi S; Decarli A; Gallus G; Regallo M; Liberati A; Tognoni G
    Am J Epidemiol; 1984 Jul; 120(1):115-22. PubMed ID: 6741913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.